Aarey Drugs Approves Allotment of 1.15 Million Shares on Warrant Conversion
Aarey Drugs & Pharmaceuticals Ltd 路 Revision of outcome 路 07 Oct 2026, 8:30 pm
Aarey Drugs Approves Allotment of 1.15 Million Shares on Warrant Conversion Aarey Drugs & Pharmaceuticals' board approved the allotment of 1.15 million equity shares of face value Rs. 10 each on 30th Sep'26 upon conversion of preferential warrants. The conversion occurred at an issue price of Rs. 63.80 per warrant (premium of Rs. 53.80) following the receipt of Rs. 47.85 per warrant (75% balance), aggregating to Rs. 55.03 million. Consequently, total paid-up equity expanded to 31.87 million shares (Rs. 318.74 million), with 1.48 million warrants remaining outstanding for conversion out of the original 5.0 million issued.
Original exchange filing (PDF)
More announcements from Aarey Drugs & Pharmaceuticals Ltd
- Statement of deviation and variation for the quarter ended September 30, 2026 路 15 Nov 2026
- As per attachment 路 15 Nov 2026
- 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026 along with .... 路 15 Nov 2026
- Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve This is to intimate .... 路 14 Nov 2026
- Scrutinizers Report of 36th Annual General Meeting 路 06 Oct 2026
